3,4-dihydroxyphenylacetic acid has been researched along with azides in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biggio, G; Corda, MG; Giorgi, O | 1 |
| Colombo, G; Fadda, F; Gessa, GL; Mosca, E; Niffoi, T | 1 |
| Beal, MF; Brouillet, E; Henshaw, DR; Hyman, BT; Jenkins, BG; Rosen, BR; Schulz, JB; Sodhi, P | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylacetic acid and azides
| Article | Year |
|---|---|
Ro 15-4513, like anxiogenic beta-carbolines, increases dopamine metabolism in the prefrontal cortex of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Affinity Labels; Animals; Appetite Depressants; Azides; Benzodiazepines; Carbolines; Cerebral Cortex; Dopamine; Male; Rats; Rats, Inbred Strains | 1988 |
Ethanol prevents stress-induced increase in cortical DOPAC: reversal by RO 15-4513.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Azides; Benzodiazepines; Diazepam; Electroshock; Ethanol; Male; Phenylacetates; Rats; Stress, Physiological | 1987 |
Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Aging; Animals; Azides; Biogenic Amines; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Functional Laterality; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Homovanillic Acid; Injections, Intraperitoneal; Lactates; Magnetic Resonance Imaging; Male; Microinjections; NADPH Dehydrogenase; Neurons; Neuropeptide Y; Neuropeptides; Neurotoxins; Oxidative Phosphorylation; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sodium Azide; Somatostatin; Substance P | 1994 |